Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fate”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Not applicableStudy completedNCT06751368
What this trial is testing

The Fate of Aortic Valve After SAS Surgery in Children

Who this might be right for
Subaortic StenosisCongenital Heart DiseaseAortic Regurgitation
Chinese Academy of Medical Sciences, Fuwai Hospital 232
Not applicableStudy completedNCT04298346
What this trial is testing

Neurological Fate, Prematurity and Genetic Susceptibility Factors

Who this might be right for
Polymorphism, Restriction Fragment LengthPrematureInfertility of Cervical Origin
Nantes University Hospital 27
Not applicableUnknownNCT05566119
What this trial is testing

L5-S1 Disc Fate in Thoracolumbar Arthrodesis Stopping at L5

Who this might be right for
Spinal Deformity
Fondation Hôpital Saint-Joseph 17
Not applicableStudy completedNCT05669612
What this trial is testing

Promephy - Metabolic Fate of Plant-based Proteins

Who this might be right for
Amino Acid ChangeGastrointestinal Dysfunction
Anglia Ruskin University 20
Not applicableUnknownNCT01750671
What this trial is testing

Influence Of Nutritional Status Of Patients In The Intensive Care Output On Long Term Fate

Who this might be right for
Nutritional Status at the Release of ICU.
University Hospital, Clermont-Ferrand 680
Not applicableEnded earlyNCT04106167
What this trial is testing

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Who this might be right for
Advanced Solid TumorLymphomaGastric Cancer+15 more
Fate Therapeutics 20
Early research (Phase 1)Study completedNCT03245229
What this trial is testing

A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood)

Who this might be right for
Healthy Subjects
Idorsia Pharmaceuticals Ltd. 20
Early research (Phase 1)Looking for participantsNCT06308978
What this trial is testing

FT819 in B-cell Mediated Autoimmune Disease

Who this might be right for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Systemic Sclerosis (SSc)+2 more
Fate Therapeutics 244
Not applicableStudy completedNCT00431899
What this trial is testing

Effects of Omega 3 in Hemodialysis Patients

Who this might be right for
HemodialysisEnd Stage Renal Disease
Laboratoire Régional de Nutrition Humaine 8
Not applicableStudy completedNCT06824675
What this trial is testing

Point-of-care Ultrasound Teledidactic Teaching for Prehospital Emergency Personnel

Who this might be right for
eFastFateEducation, Medical+1 more
Medical University of Vienna 90
Not applicableUnknownNCT04464278
What this trial is testing

Variation in Body Composition on the Fate of Older Subjects During SSR Hospitalization

Who this might be right for
Body Weight Changes
Assistance Publique - Hôpitaux de Paris 360
Early research (Phase 1)Study completedNCT03593278
What this trial is testing

Evaluate ACT-246475 Fate in Healthy Male Subjects

Who this might be right for
Healthy Subjects
Viatris Innovation GmbH 6
Early research (Phase 1)Study completedNCT03596294
What this trial is testing

A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of Clazosentan

Who this might be right for
Healthy Subjects
Idorsia Pharmaceuticals Ltd. 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07570862
What this trial is testing

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more
Fate Therapeutics 53
Not applicableStudy completedNCT01418469
What this trial is testing

Disturbances in BCAA Metabolism and the Effects of Feeding and Exercise in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Maastricht University Medical Center 24
Not applicableStudy completedNCT05836363
What this trial is testing

Fate at Long-term of Mild to Moderate Bicuspid Aortic Valve Disease Left Untreated at the Time of Supracoronary Ascending Aorta Replacement

Who this might be right for
Bicuspid Aortic ValveAscending Aorta Aneurysm
Michele De Bonis 75
Early research (Phase 1)Study completedNCT03372629
What this trial is testing

Evaluate if ID-085 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects

Who this might be right for
Healthy Subjects
Idorsia Pharmaceuticals Ltd. 88
Not applicableStudy completedNCT06630481
What this trial is testing

Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade

Who this might be right for
Pancreatic CancerNeoadjuvant TherapyPathological Complete Response
Seoul National University Hospital 462
Early research (Phase 1)Study completedNCT04555811
What this trial is testing

FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL

Who this might be right for
NHLNon Hodgkin LymphomaDiffuse Large B Cell Lymphoma+1 more
Masonic Cancer Center, University of Minnesota 7
Not applicableStudy completedNCT02719899
What this trial is testing

Effect of Fasting and Refeeding on T-cell Fate

Who this might be right for
AsthmaInflammation
National Heart, Lung, and Blood Institute (NHLBI) 28
Load More Results